欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0343/001
药品名称
Menavir
活性成分
brivudine 125.0 mg
剂型
Tablet
上市许可持有人
Berlin-Chemie AG Glienicker Weg 125 D-12489 Berlin
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2002/03/05
最近更新日期
2019/12/13
药物ATC编码
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
00_Menavir_OuterBox
Date of last change:2024/09/06
Final SPC
|
DE_341_IB_1517_DE_342_IB_1618_DE 343_IB_1719_day 20
Date of last change:2024/09/06
Final Product Information
|
DE341_Premovir_PI_clean_20150730_renewal _1_
Date of last change:2024/09/06
Final Product Information
|
DE342_Zostex_PI_clean_20150730_renewal _2_
Date of last change:2024/09/06
Final Product Information
|
DE343_Menavir_PI_clean_20150730_renewal _3_
Date of last change:2024/09/06
Final PL
|
Menavir_PL
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase